{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T01:57:05Z","timestamp":1788573425956,"version":"build-2803163510"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,1,24]],"date-time":"2019-01-24T00:00:00Z","timestamp":1548288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,1,24]],"date-time":"2019-01-24T00:00:00Z","timestamp":1548288000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Albuminuria affects millions of people, and is an independent risk factor for kidney failure, cardiovascular morbidity and death. The key cell that prevents albuminuria is the terminally differentiated glomerular podocyte. Here we report the evolutionary importance of the enzyme Glycogen Synthase Kinase 3 (GSK3) for maintaining podocyte function in mice and the equivalent nephrocyte cell in\n                    <jats:italic>Drosophila<\/jats:italic>\n                    . Developmental deletion of both GSK3 isoforms (\u03b1 and \u03b2) in murine podocytes causes late neonatal death associated with massive albuminuria and renal failure. Similarly, silencing GSK3 in nephrocytes is developmentally lethal for this cell. Mature genetic or pharmacological podocyte\/nephrocyte GSK3 inhibition is also detrimental; producing albuminuric kidney disease in mice and nephrocyte depletion in\n                    <jats:italic>Drosophila<\/jats:italic>\n                    . Mechanistically, GSK3 loss causes differentiated podocytes to re-enter the cell cycle and undergo mitotic catastrophe, modulated via the Hippo pathway but independent of Wnt-\u03b2-catenin. This work clearly identifies GSK3 as a critical regulator of podocyte and hence kidney function.\n                  <\/jats:p>","DOI":"10.1038\/s41467-018-08235-1","type":"journal-article","created":{"date-parts":[[2019,1,24]],"date-time":"2019-01-24T06:05:12Z","timestamp":1548309912000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":75,"title":["Podocyte GSK3 is an evolutionarily conserved critical regulator of kidney function"],"prefix":"10.1038","volume":"10","author":[{"given":"J. A.","family":"Hurcombe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Hartley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. C.","family":"Lay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. J.","family":"Bedford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. P.","family":"Leader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. L.","family":"Scudamore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Marquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. F.","family":"Barrington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Pinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Marchetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4348-698X","authenticated-orcid":false,"given":"L.-F.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Uney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. A.","family":"Saleem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. W.","family":"Mathieson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3366-0956","authenticated-orcid":false,"given":"R. J.","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3731-5797","authenticated-orcid":false,"given":"J. R.","family":"Woodgett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. E.","family":"Quaggin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. I.","family":"Welsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. J. M.","family":"Coward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,1,24]]},"reference":[{"key":"8235_CR1","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/S0140-6736(13)60439-0","volume":"382","author":"KU Eckardt","year":"2013","unstructured":"Eckardt, K. U. et al. Evolving importance of kidney disease: from subspecialty to global health burden. Lancet 382, 158\u2013169 (2013).","journal-title":"Lancet"},{"key":"8235_CR2","doi-asserted-by":"publisher","first-page":"2034","DOI":"10.1681\/ASN.2005101085","volume":"17","author":"M Tonelli","year":"2006","unstructured":"Tonelli, M. et al. Chronic kidney disease and mortality risk: a systematic review. J. Am. Soc. Nephrol. 17, 2034\u20132047 (2006).","journal-title":"J. Am. Soc. Nephrol."},{"key":"8235_CR3","doi-asserted-by":"publisher","first-page":"e207","DOI":"10.1371\/journal.pmed.0050207","volume":"5","author":"V Perkovic","year":"2008","unstructured":"Perkovic, V. et al. The relationship between proteinuria and coronary risk: a systematic review and meta-analysis. PLoS Med. 5, e207 (2008).","journal-title":"PLoS Med."},{"key":"8235_CR4","doi-asserted-by":"publisher","first-page":"e93999","DOI":"10.1371\/journal.pone.0093999","volume":"9","author":"Y Sun","year":"2014","unstructured":"Sun, Y. et al. The expression and significance of neuronal iconic proteins in podocytes. PLoS ONE 9, e93999 (2014).","journal-title":"PLoS ONE"},{"key":"8235_CR5","first-page":"226","volume":"5","author":"A Bierzynska","year":"2014","unstructured":"Bierzynska, A., Soderquest, K. & Koziell, A. Genes and podocytes - new insights into mechanisms of podocytopathy. Front Endocrinol. 5, 226 (2014).","journal-title":"Front Endocrinol."},{"key":"8235_CR6","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.gde.2009.08.006","volume":"19","author":"B Denholm","year":"2009","unstructured":"Denholm, B. & Skaer, H. Bringing together components of the fly renal system. Curr. Opin. Genet. Dev. 19, 526\u2013532 (2009).","journal-title":"Curr. Opin. Genet. Dev."},{"key":"8235_CR7","doi-asserted-by":"publisher","first-page":"e1000532","DOI":"10.1371\/journal.pgen.1000532","volume":"5","author":"SF Soukup","year":"2009","unstructured":"Soukup, S. F., Culi, J. & Gubb, D. Uptake of the necrotic serpin in Drosophila melanogaster via the lipophorin receptor-1. PLoS Genet. 5, e1000532 (2009).","journal-title":"PLoS Genet."},{"key":"8235_CR8","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.tibs.2003.12.004","volume":"29","author":"RS Jope","year":"2004","unstructured":"Jope, R. S. & Johnson, G. V. The glamour and gloom of glycogen synthase kinase-3. Trends Biochem. Sci. 29, 95\u2013102 (2004).","journal-title":"Trends Biochem. Sci."},{"key":"8235_CR9","doi-asserted-by":"publisher","first-page":"101","DOI":"10.2174\/1566524024605761","volume":"2","author":"PJ Roach","year":"2002","unstructured":"Roach, P. J. Glycogen and its metabolism. Curr. Mol. Med. 2, 101\u2013120 (2002).","journal-title":"Curr. Mol. Med."},{"key":"8235_CR10","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/S0165-6147(03)00206-2","volume":"24","author":"RS Jope","year":"2003","unstructured":"Jope, R. S. Lithium and GSK-3: one inhibitor, two inhibitory actions, multiple outcomes. Trends Pharmacol. Sci. 24, 441\u2013443 (2003).","journal-title":"Trends Pharmacol. Sci."},{"key":"8235_CR11","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.tplants.2011.10.002","volume":"17","author":"Y Saidi","year":"2012","unstructured":"Saidi, Y., Hearn, T. J. & Coates, J. C. Function and evolution of \u2018green\u2019 GSK3\/Shaggy-like kinases. Trends Plant. Sci. 17, 39\u201346 (2012).","journal-title":"Trends Plant. Sci."},{"key":"8235_CR12","doi-asserted-by":"publisher","first-page":"2431","DOI":"10.1002\/j.1460-2075.1990.tb07419.x","volume":"9","author":"JR Woodgett","year":"1990","unstructured":"Woodgett, J. R. Molecular cloning and expression of glycogen synthase kinase-3\/factor A. EMBO J. 9, 2431\u20132438 (1990).","journal-title":"EMBO J."},{"key":"8235_CR13","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1016\/S1097-2765(01)00253-2","volume":"7","author":"S Frame","year":"2001","unstructured":"Frame, S., Cohen, P. & Biondi, R. M. A common phosphate binding site explains the unique substrate specificity of GSK3 and its inactivation by phosphorylation. Mol. Cell 7, 1321\u20131327 (2001).","journal-title":"Mol. Cell"},{"key":"8235_CR14","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/35017574","volume":"406","author":"KP Hoeflich","year":"2000","unstructured":"Hoeflich, K. P. et al. Requirement for glycogen synthase kinase-3beta in cell survival and NF-kappaB activation. Nature 406, 86\u201390 (2000).","journal-title":"Nature"},{"key":"8235_CR15","doi-asserted-by":"publisher","first-page":"3609","DOI":"10.1172\/JCI36245","volume":"118","author":"R Kerkela","year":"2008","unstructured":"Kerkela, R. et al. Deletion of GSK-3beta in mice leads to hypertrophic cardiomyopathy secondary to cardiomyoblast hyperproliferation. J. Clin. Invest. 118, 3609\u20133618 (2008).","journal-title":"J. Clin. Invest."},{"key":"8235_CR16","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.cmet.2007.08.013","volume":"6","author":"K MacAulay","year":"2007","unstructured":"MacAulay, K. et al. Glycogen synthase kinase 3alpha-specific regulation of murine hepatic glycogen metabolism. Cell Metab. 6, 329\u2013337 (2007).","journal-title":"Cell Metab."},{"key":"8235_CR17","doi-asserted-by":"publisher","first-page":"6314","DOI":"10.1128\/MCB.00763-08","volume":"28","author":"S Patel","year":"2008","unstructured":"Patel, S. et al. Tissue-specific role of glycogen synthase kinase 3beta in glucose homeostasis and insulin action. Mol. Cell. Biol. 28, 6314\u20136328 (2008).","journal-title":"Mol. Cell. Biol."},{"key":"8235_CR18","doi-asserted-by":"publisher","first-page":"3702","DOI":"10.1210\/en.2013-1155","volume":"154","author":"JR Gillespie","year":"2013","unstructured":"Gillespie, J. R. et al. GSK-3beta function in bone regulates skeletal development, whole-body metabolism, and male life span. Endocrinology 154, 3702\u20133718 (2013).","journal-title":"Endocrinology"},{"key":"8235_CR19","doi-asserted-by":"publisher","first-page":"e43262","DOI":"10.1371\/journal.pone.0043262","volume":"7","author":"W Zhou","year":"2012","unstructured":"Zhou, W. et al. The effects of glycogen synthase kinase-3beta in serotonin neurons. PLoS ONE 7, e43262 (2012).","journal-title":"PLoS ONE"},{"key":"8235_CR20","doi-asserted-by":"publisher","first-page":"7392","DOI":"10.1523\/JNEUROSCI.0889-12.2012","volume":"32","author":"DE Hurtado","year":"2012","unstructured":"Hurtado, D. E. et al. Selectively silencing GSK-3 isoforms reduces plaques and tangles in mouse models of Alzheimer\u2019s disease. J. Neurosci. 32, 7392\u20137402 (2012).","journal-title":"J. Neurosci."},{"key":"8235_CR21","doi-asserted-by":"publisher","first-page":"40","DOI":"10.3389\/fnmol.2011.00040","volume":"4","author":"O Kaidanovich-Beilin","year":"2011","unstructured":"Kaidanovich-Beilin, O. & Woodgett, J. R. GSK-3: Functional Insights from Cell Biology and Animal Models. Front. Mol. Neurosci. 4, 40 (2011).","journal-title":"Front. Mol. Neurosci."},{"key":"8235_CR22","doi-asserted-by":"crossref","unstructured":"Zhou, S. et al. Genetic and pharmacologic targeting of glycogen synthase kinase 3beta reinforces the Nrf2 antioxidant defense against podocytopathy. J. Am. Soc. Nephrol. 27, 2289\u20132308 (2016).","DOI":"10.1681\/ASN.2015050565"},{"key":"8235_CR23","doi-asserted-by":"publisher","first-page":"F1152","DOI":"10.1152\/ajprenal.00373.2010","volume":"300","author":"B George","year":"2011","unstructured":"George, B. et al. GSK3beta inactivation in podocytes results in decreased phosphorylation of p70S6K accompanied by cytoskeletal rearrangements and inhibited motility. Am. J. Physiol. Ren. Physiol. 300, F1152\u2013F1162 (2011).","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"8235_CR24","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1159\/000358678","volume":"33","author":"J Guo","year":"2014","unstructured":"Guo, J. et al. GSK-3beta and vitamin D receptor are involved in beta-catenin and snail signaling in high glucose-induced epithelial-mesenchymal transition of mouse podocytes. Cell. Physiol. Biochem. 33, 1087\u20131096 (2014).","journal-title":"Cell. Physiol. Biochem."},{"key":"8235_CR25","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1111\/bph.12952","volume":"172","author":"Z Wang","year":"2015","unstructured":"Wang, Z. et al. Pharmacological targeting of GSK3beta confers protection against podocytopathy and proteinuria by desensitizing mitochondrial permeability transition. Br. J. Pharmacol. 172, 895\u2013909 (2015).","journal-title":"Br. J. Pharmacol."},{"key":"8235_CR26","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1074\/jbc.M114.593830","volume":"290","author":"W Xu","year":"2015","unstructured":"Xu, W., Ge, Y., Liu, Z. & Gong, R. Glycogen synthase kinase 3beta orchestrates microtubule remodeling in compensatory glomerular adaptation to podocyte depletion. J. Biol. Chem. 290, 1348\u20131363 (2015).","journal-title":"J. Biol. Chem."},{"key":"8235_CR27","doi-asserted-by":"crossref","first-page":"39493","DOI":"10.18632\/oncotarget.6303","volume":"6","author":"C Li","year":"2015","unstructured":"Li, C., Ge, Y., Peng, A. & Gong, R. The redox sensitive glycogen synthase kinase 3beta suppresses the self-protective antioxidant response in podocytes upon oxidative glomerular injury. Oncotarget 6, 39493\u201339506 (2015).","journal-title":"Oncotarget"},{"key":"8235_CR28","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1681\/ASN.V1181439","volume":"11","author":"GS Markowitz","year":"2000","unstructured":"Markowitz, G. S. et al. Lithium nephrotoxicity: a progressive combined glomerular and tubulointerstitial nephropathy. J. Am. Soc. Nephrol. 11, 1439\u20131448 (2000).","journal-title":"J. Am. Soc. Nephrol."},{"key":"8235_CR29","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/ki.1977.102","volume":"12","author":"J Hestbech","year":"1977","unstructured":"Hestbech, J., Hansen, H. E., Amdisen, A. & Olsen, S. Chronic renal lesions following long-term treatment with lithium. Kidney Int. 12, 205\u2013213 (1977).","journal-title":"Kidney Int."},{"key":"8235_CR30","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1681\/ASN.2015080907","volume":"27","author":"M Alsady","year":"2016","unstructured":"Alsady, M., Baumgarten, R., Deen, P. M. & de Groot, T. Lithium in the kidney: friend and foe? J. Am. Soc. Nephrol. 27, 1587\u20131595 (2016).","journal-title":"J. Am. Soc. Nephrol."},{"key":"8235_CR31","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1681\/ASN.V133788","volume":"13","author":"V Eremina","year":"2002","unstructured":"Eremina, V., Wong, M. A., Cui, S., Schwartz, L. & Quaggin, S. E. Glomerular-specific gene excision in vivo. J. Am. Soc. Nephrol. 13, 788\u2013793 (2002).","journal-title":"J. Am. Soc. Nephrol."},{"key":"8235_CR32","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1002\/med.10011","volume":"22","author":"A Martinez","year":"2002","unstructured":"Martinez, A., Castro, A., Dorronsoro, I. & Alonso, M. Glycogen synthase kinase 3 (GSK-3) inhibitors as new promising drugs for diabetes, neurodegeneration, cancer, and inflammation. Med. Res. Rev. 22, 373\u2013384 (2002).","journal-title":"Med. Res. Rev."},{"key":"8235_CR33","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1038\/nrd1415","volume":"3","author":"P Cohen","year":"2004","unstructured":"Cohen, P. & Goedert, M. GSK3 inhibitors: development and therapeutic potential. Nat. Rev. Drug. Discov. 3, 479\u2013487 (2004).","journal-title":"Nat. Rev. Drug. Discov."},{"key":"8235_CR34","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1038\/nature07526","volume":"457","author":"H Weavers","year":"2009","unstructured":"Weavers, H. et al. The insect nephrocyte is a podocyte-like cell with a filtration slit diaphragm. Nature 457, 322\u2013326 (2009).","journal-title":"Nature"},{"key":"8235_CR35","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1038\/nn.2408","volume":"12","author":"WY Kim","year":"2009","unstructured":"Kim, W. Y. et al. GSK-3 is a master regulator of neural progenitor homeostasis. Nat. Neurosci. 12, 1390\u20131397 (2009).","journal-title":"Nat. Neurosci."},{"key":"8235_CR36","doi-asserted-by":"publisher","first-page":"3514","DOI":"10.1038\/onc.2014.279","volume":"34","author":"J Dembowy","year":"2015","unstructured":"Dembowy, J., Adissu, H. A., Liu, J. C., Zacksenhaus, E. & Woodgett, J. R. Effect of glycogen synthase kinase-3 inactivation on mouse mammary gland development and oncogenesis. Oncogene 34, 3514\u20133526 (2015).","journal-title":"Oncogene"},{"key":"8235_CR37","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/S0092-8674(00)80718-7","volume":"97","author":"Y Wei","year":"1999","unstructured":"Wei, Y., Yu, L., Bowen, J., Gorovsky, M. A. & Allis, C. D. Phosphorylation of histone H3 is required for proper chromosome condensation and segregation. Cell 97, 99\u2013109 (1999).","journal-title":"Cell"},{"key":"8235_CR38","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1093\/ndt\/gfu395","volume":"30","author":"D Thomasova","year":"2015","unstructured":"Thomasova, D. & Anders, H. J. Cell cycle control in the kidney. Nephrol. Dial. Transplant. 30, 1622\u20131630 (2015).","journal-title":"Nephrol. Dial. Transplant."},{"key":"8235_CR39","first-page":"335","volume":"5","author":"LA Porter","year":"2003","unstructured":"Porter, L. A. & Donoghue, D. J. Cyclin B1 and CDK1: nuclear localization and upstream regulators. Prog. Cell Cycle Res. 5, 335\u2013347 (2003).","journal-title":"Prog. Cell Cycle Res."},{"key":"8235_CR40","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.cell.2011.04.009","volume":"145","author":"C Badouel","year":"2011","unstructured":"Badouel, C. & McNeill, H. SnapShot: The hippo signaling pathway. Cell 145, 484\u2013484 e481 (2011).","journal-title":"Cell"},{"key":"8235_CR41","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1038\/ncb3216","volume":"17","author":"F Zanconato","year":"2015","unstructured":"Zanconato, F. et al. Genome-wide association between YAP\/TAZ\/TEAD and AP-1 at enhancers drives oncogenic growth. Nat. Cell Biol. 17, 1218\u20131227 (2015).","journal-title":"Nat. Cell Biol."},{"key":"8235_CR42","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1242\/dev.102376","volume":"141","author":"X Varelas","year":"2014","unstructured":"Varelas, X. The Hippo pathway effectors TAZ and YAP in development, homeostasis and disease. Development 141, 1614\u20131626 (2014).","journal-title":"Development"},{"key":"8235_CR43","doi-asserted-by":"crossref","first-page":"668","DOI":"10.18632\/oncotarget.23089","volume":"9","author":"X Chen","year":"2018","unstructured":"Chen, X. et al. C-MYC and BCL-2 mediate YAP-regulated tumorigenesis in OSCC. Oncotarget 9, 668\u2013679 (2018).","journal-title":"Oncotarget"},{"key":"8235_CR44","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1038\/ncb1508","volume":"8","author":"JI Yook","year":"2006","unstructured":"Yook, J. I. et al. A Wnt-Axin2-GSK3beta cascade regulates Snail1 activity in breast cancer cells. Nat. Cell Biol. 8, 1398\u20131406 (2006).","journal-title":"Nat. Cell Biol."},{"key":"8235_CR45","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/ng1296","volume":"36","author":"ES Emamian","year":"2004","unstructured":"Emamian, E. S., Hall, D., Birnbaum, M. J., Karayiorgou, M. & Gogos, J. A. Convergent evidence for impaired AKT1-GSK3beta signaling in schizophrenia. Nat. Genet. 36, 131\u2013137 (2004).","journal-title":"Nat. Genet."},{"key":"8235_CR46","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1038\/nm1552","volume":"13","author":"CM Trivedi","year":"2007","unstructured":"Trivedi, C. M. et al. Hdac2 regulates the cardiac hypertrophic response by modulating Gsk3 beta activity. Nat. Med. 13, 324\u2013331 (2007).","journal-title":"Nat. Med."},{"key":"8235_CR47","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1097\/01.ASN.0000102468.37809.C6","volume":"15","author":"MJ Moeller","year":"2004","unstructured":"Moeller, M. J. et al. Podocytes populate cellular crescents in a murine model of inflammatory glomerulonephritis. J. Am. Soc. Nephrol. 15, 61\u201367 (2004).","journal-title":"J. Am. Soc. Nephrol."},{"key":"8235_CR48","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/nm.2550","volume":"18","author":"M Shkreli","year":"2011","unstructured":"Shkreli, M. et al. Reversible cell-cycle entry in adult kidney podocytes through regulated control of telomerase and Wnt signaling. Nat. Med. 18, 111\u2013119 (2011).","journal-title":"Nat. Med."},{"key":"8235_CR49","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1517\/14728222.12.10.1265","volume":"12","author":"K MacAulay","year":"2008","unstructured":"MacAulay, K. & Woodgett, J. R. Targeting glycogen synthase kinase-3 (GSK-3) in the treatment of Type 2 diabetes. Expert. Opin. Ther. Targets 12, 1265\u20131274 (2008).","journal-title":"Expert. Opin. Ther. Targets"},{"key":"8235_CR50","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1161\/CIRCRESAHA.116.303613","volume":"116","author":"H Lal","year":"2015","unstructured":"Lal, H., Ahmad, F., Woodgett, J. & Force, T. The GSK-3 family as therapeutic target for myocardial diseases. Circ. Res. 116, 138\u2013149 (2015).","journal-title":"Circ. Res."},{"key":"8235_CR51","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.pharmthera.2014.11.016","volume":"148","author":"E Beurel","year":"2015","unstructured":"Beurel, E., Grieco, S. F. & Jope, R. S. Glycogen synthase kinase-3 (GSK3): regulation, actions, and diseases. Pharmacol. Ther. 148, 114\u2013131 (2015).","journal-title":"Pharmacol. Ther."},{"key":"8235_CR52","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3389\/fnmol.2012.00014","volume":"5","author":"L Freland","year":"2012","unstructured":"Freland, L. & Beaulieu, J. M. Inhibition of GSK3 by lithium, from single molecules to signaling networks. Front. Mol. Neurosci. 5, 14 (2012).","journal-title":"Front. Mol. Neurosci."},{"key":"8235_CR53","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1097\/YIC.0b013e32836435e2","volume":"28","author":"A Dols","year":"2013","unstructured":"Dols, A. et al. The prevalence and management of side effects of lithium and anticonvulsants as mood stabilizers in bipolar disorder from a clinical perspective: a review. Int. Clin. Psychopharmacol. 28, 287\u2013296 (2013).","journal-title":"Int. Clin. Psychopharmacol."},{"key":"8235_CR54","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1177\/0269881115573808","volume":"29","author":"H Aiff","year":"2015","unstructured":"Aiff, H. et al. Effects of 10 to 30 years of lithium treatment on kidney function. J. Psychopharmacol. 29, 608\u2013614 (2015).","journal-title":"J. Psychopharmacol."},{"key":"8235_CR55","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/ki.2009.433","volume":"77","author":"H Bendz","year":"2010","unstructured":"Bendz, H., Schon, S., Attman, P. O. & Aurell, M. Renal failure occurs in chronic lithium treatment but is uncommon. Kidney Int. 77, 219\u2013224 (2010).","journal-title":"Kidney Int."},{"key":"8235_CR56","first-page":"577","volume":"48","author":"HE Hansen","year":"1979","unstructured":"Hansen, H. E. et al. Chronic interstitial nephropathy in patients on long-term lithium treatment. Q. J. Med. 48, 577\u2013591 (1979).","journal-title":"Q. J. Med."},{"key":"8235_CR57","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/ki.1981.191","volume":"20","author":"M Aurell","year":"1981","unstructured":"Aurell, M., Svalander, C., Wallin, L. & Alling, C. Renal function and biopsy findings in patients on long-term lithium treatment. Kidney Int. 20, 663\u2013670 (1981).","journal-title":"Kidney Int."},{"key":"8235_CR58","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1038\/nrneph.2015.88","volume":"11","author":"L Zhou","year":"2015","unstructured":"Zhou, L. & Liu, Y. Wnt\/beta-catenin signalling and podocyte dysfunction in proteinuric kidney disease. Nat. Rev. Nephrol. 11, 535\u2013545 (2015).","journal-title":"Nat. Rev. Nephrol."},{"key":"8235_CR59","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1161\/CIRCRESAHA.116.308544","volume":"118","author":"J Zhou","year":"2016","unstructured":"Zhou, J. et al. Loss of adult cardiac myocyte GSK-3 leads to mitotic catastrophe resulting in fatal dilated cardiomyopathy. Circ. Res. 118, 1208\u20131222 (2016).","journal-title":"Circ. Res."},{"key":"8235_CR60","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.cell.2014.06.013","volume":"158","author":"L Azzolin","year":"2014","unstructured":"Azzolin, L. et al. YAP\/TAZ incorporation in the beta-catenin destruction complex orchestrates the Wnt response. Cell 158, 157\u2013170 (2014).","journal-title":"Cell"},{"key":"8235_CR61","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1056\/NEJMoa0707330","volume":"358","author":"V Eremina","year":"2008","unstructured":"Eremina, V. et al. VEGF inhibition and renal thrombotic microangiopathy. N. Engl. J. Med. 358, 1129\u20131136 (2008).","journal-title":"N. Engl. J. Med."},{"key":"8235_CR62","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1002\/dvg.20335","volume":"45","author":"MD Muzumdar","year":"2007","unstructured":"Muzumdar, M. D., Tasic, B., Miyamichi, K., Li, L. & Luo, L. A global double-fluorescent Cre reporter mouse. Genesis 45, 593\u2013605 (2007).","journal-title":"Genesis"},{"key":"8235_CR63","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1242\/dev.128.8.1253","volume":"128","author":"V Brault","year":"2001","unstructured":"Brault, V. et al. Inactivation of the beta-catenin gene by Wnt1-Cre-mediated deletion results in dramatic brain malformation and failure of craniofacial development. Development 128, 1253\u20131264 (2001).","journal-title":"Development"},{"key":"8235_CR64","doi-asserted-by":"publisher","first-page":"e0134620","DOI":"10.1371\/journal.pone.0134620","volume":"10","author":"JR Ivy","year":"2015","unstructured":"Ivy, J. R. et al. Klf15 is critical for the development and differentiation of drosophila nephrocytes. PLoS ONE 10, e0134620 (2015).","journal-title":"PLoS ONE"},{"key":"8235_CR65","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1681\/ASN.V133630","volume":"13","author":"MA Saleem","year":"2002","unstructured":"Saleem, M. A. et al. A conditionally immortalized human podocyte cell line demonstrating nephrin and podocin expression. J. Am. Soc. Nephrol. 13, 630\u2013638 (2002).","journal-title":"J. Am. Soc. Nephrol."},{"key":"8235_CR66","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1074\/mcp.M115.057315","volume":"15","author":"MC Wilson","year":"2016","unstructured":"Wilson, M. C. et al. Comparison of the proteome of adult and cord erythroid cells, and changes in the proteome following reticulocyte maturation. Mol. Cell. Proteom. 15, 1938\u20131946 (2016).","journal-title":"Mol. Cell. Proteom."},{"key":"8235_CR67","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/nbt.2839","volume":"32","author":"JA Vizcaino","year":"2014","unstructured":"Vizcaino, J. A. et al. ProteomeXchange provides globally coordinated proteomics data submission and dissemination. Nat. Biotechnol. 32, 223\u2013226 (2014).","journal-title":"Nat. Biotechnol."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-08235-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-08235-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-08235-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,16]],"date-time":"2022-12-16T14:32:21Z","timestamp":1671201141000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-08235-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,24]]},"references-count":67,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["8235"],"URL":"https:\/\/doi.org\/10.1038\/s41467-018-08235-1","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.734925343.793559121","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,24]]},"assertion":[{"value":"10 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"403"}}